FILTON STEVE 4
4 · UNIVERSAL HEALTH SERVICES INC · Filed Mar 13, 2026
Research Summary
AI-generated summary of this filing
Universal Health (UHS) CFO Steve Filton Exercises Options, Withholds Shares
What Happened Steve Filton, Executive Vice President & Chief Financial Officer of Universal Health Services (UHS), exercised stock options on 2026-03-12 to acquire 83,237 shares (39,200 @ $138.80 = $5,440,960 and 44,037 @ $152.68 = $6,723,569; total ≈ $12.16M). To cover exercise costs and tax withholding, 78,570 shares were surrendered/withheld (71,752 @ $192.28 = $13,796,475 and 6,818 @ $190.49 = $1,298,761; total ≈ $15.10M). In addition, 16,044 performance-based restricted stock units (RSUs) vested and were issued to him (no cash value shown in the filing).
Key Details
- Transaction date: March 12, 2026 (Form 4 filed March 13, 2026 — timely)
- Option exercises (Reporting code M): 39,200 @ $138.80 and 44,037 @ $152.68 (acquired)
- Withheld/disposed for taxes or exercise payment (code F): 71,752 @ $192.28 and 6,818 @ $190.49 (disposed)
- Grant/award (code A): 16,044 RSU shares issued upon vesting (value reported $0 in filing)
- Footnotes: F1 — the 16,044 RSU shares vested from a March 15, 2023 performance award; F2 — the option(s) vested ratably on 3/17/2022, 3/17/2023, 3/17/2024 and 3/17/2025
- Shares owned after transaction: not specified in the provided filing excerpt
- Filing timeliness: filed the next day (not marked late)
Context This was an options exercise with simultaneous withholding/surrender of shares to satisfy exercise costs and tax obligations (a common "sell-to-cover" or net-withholding approach), rather than an open-market sale for investment purposes. The RSU issuance reflects performance-based vesting from a prior award and was not previously reportable until vesting criteria were met. These actions are routine insider compensation and tax-related transactions and should be interpreted as such.
Insider Transaction Report
- Exercise/Conversion
Class B Common Stock
2026-03-12$138.80/sh+39,200$5,440,960→ 157,701 total - Exercise/Conversion
Class B Common Stock
2026-03-12$152.68/sh+44,037$6,723,569→ 201,738 total - Tax Payment
Class B Common Stock
2026-03-12$192.28/sh−71,752$13,796,475→ 129,986 total - Award
Class B Common Stock
[F1]2026-03-12+16,044→ 146,030 total - Tax Payment
Class B Common Stock
2026-03-12$190.49/sh−6,818$1,298,761→ 139,212 total - Exercise/Conversion
Option To Purchase Class B Common Stock
[F2]2026-03-12−39,200→ 0 totalExercise: $138.80Exp: 2026-03-16→ Class B Common Stock (39,200 underlying) - Exercise/Conversion
Option To Purchase Class B Common Stock
[F2]2026-03-12−44,037→ 0 totalExercise: $152.68Exp: 2026-03-16→ Class B Common Stock (44,037 underlying)
- 80,500(indirect: By Trust)
Class B Common Stock
- 80,500(indirect: By Trust)
Class B Common Stock
Footnotes (2)
- [F1]Represents shares of Class B Common Stock issued upon the vesting of the performance-based restricted stock units ("RSUs") awarded to the Reporting Person on March 15, 2023, which vested based on the Issuer's satisfaction of certain performance criteria. In light of the performance-based vesting criteria of the RSUs, such shares were not previously reportable under Section 16.
- [F2]Option vested ratably on each of 3/17/2022, 3/17/2023, 3/17/2024 and 3/17/2025.